Contact
searchSearch
HMP Global

News

News
Contaminated Nasal Rinse Recalled
11/03/2023
Biomic Sciences, which does business as ION Intelligence of Nature, recalls Restore Sinus Spray due to potential microbial contamination. The recall was published in the November 1, 2023, US Food and Drug Administration (FDA) Enforcement...
Biomic Sciences, which does business as ION Intelligence of Nature, recalls Restore Sinus Spray due to potential microbial contamination. The recall was published in the November 1, 2023, US Food and Drug Administration (FDA) Enforcement...
Biomic Sciences, which does...
11/03/2023
Pharmacy Learning Network
News
American Thoracic Society Initiative Focuses on COVID-19, Flu, Pneumonia Vaccination
11/03/2023
Health systems are partnering with the American Thoracic Society to collect baseline immunization data and test strategies for improving immunization rates. The plan aims to identify strategies that work in specific populations and across...
Health systems are partnering with the American Thoracic Society to collect baseline immunization data and test strategies for improving immunization rates. The plan aims to identify strategies that work in specific populations and across...
Health systems are partnering...
11/03/2023
Pharmacy Learning Network
News
Nasal Spray Recalled
11/02/2023
Biomic Sciences, which does business as ION Intelligence of Nature, is recalling ION* Sinus Support Nasal Spray because of potential microbial contamination, according to the November 1, 2023, US Food and Drug Administration (FDA) Enforcement...
Biomic Sciences, which does business as ION Intelligence of Nature, is recalling ION* Sinus Support Nasal Spray because of potential microbial contamination, according to the November 1, 2023, US Food and Drug Administration (FDA) Enforcement...
Biomic Sciences, which does...
11/02/2023
Pharmacy Learning Network
News
Sinus Spray Under Class I Recall
11/02/2023
The recalling firm, Biomic Sciences of Charlottesville, Virginia, announced FDA testing identified Microbacterium sp., Fictibacillus sp., Bacillus sp., (primarily B. malikii), and Paenibacillus sp.
The recalling firm, Biomic Sciences of Charlottesville, Virginia, announced FDA testing identified Microbacterium sp., Fictibacillus sp., Bacillus sp., (primarily B. malikii), and Paenibacillus sp.
The recalling firm, Biomic...
11/02/2023
Pharmacy Learning Network
News
A New Era of Vaccines Leaves Old Questions About Prices Unanswered
11/01/2023
The rollout of new RSV vaccines in the United States is raising questions about the cost immunization that will be given yearly to millions of Americans, and how to ensure they are distributed to those who really benefit rather than wasted on...
The rollout of new RSV vaccines in the United States is raising questions about the cost immunization that will be given yearly to millions of Americans, and how to ensure they are distributed to those who really benefit rather than wasted on...
The rollout of new RSV vaccines...
11/01/2023
Pharmacy Learning Network
News
Understanding the Scope and Impact of Perinatal Substance Use
10/30/2023
This research overview explores the issue of substance use during pregnancy including factors such as prevalence, potential causes, adverse outcomes, and the importance of universal screening and intervention to ensure healthy outcomes for...
This research overview explores the issue of substance use during pregnancy including factors such as prevalence, potential causes, adverse outcomes, and the importance of universal screening and intervention to ensure healthy outcomes for...
This research overview explores...
10/30/2023
Pharmacy Learning Network
News
Cannabidiol Can Potentially Relieve Mild to Moderate Pain in Older Adults, Study Finds
10/27/2023
Before prescribing CBD to older patients, clinicians should consider its role in the overall treatment plan and interactions with other treatment options, patient education, safety issues or concerns, and they should monitor older adults for...
Before prescribing CBD to older patients, clinicians should consider its role in the overall treatment plan and interactions with other treatment options, patient education, safety issues or concerns, and they should monitor older adults for...
Before prescribing CBD to older...
10/27/2023
Pharmacy Learning Network
News
People Who Use Opioids Are More Likely to Use a Sedative-Hypnotic Medication, Study Finds
10/27/2023
“In analyzing data from a nationally representative sample, persons who used opioids were at least 4-fold more likely to use a hypnotic than persons who did not use opioids, and adjusting for sociodemographic and clinical covariates did not...
“In analyzing data from a nationally representative sample, persons who used opioids were at least 4-fold more likely to use a hypnotic than persons who did not use opioids, and adjusting for sociodemographic and clinical covariates did not...
“In analyzing data from a...
10/27/2023
Pharmacy Learning Network
News
Class I Recall for Contaminated Mouthwash
10/26/2023
The recall classification is the FDA’s most serious and warns use of the recalled product could cause major adverse health consequences or death.
The recall classification is the FDA’s most serious and warns use of the recalled product could cause major adverse health consequences or death.
The recall classification is the...
10/26/2023
Pharmacy Learning Network
News
CDC Committee Advises Shared Decision Making for Older Adult RSV Vaccination
10/26/2023
Using shared decision making, adults aged 60 years and older may receive a single dose of a respiratory syncytial virus (RSV) vaccine, according to guidance from the Centers for Disease Control and Prevention’s Advisory Committee on...
Using shared decision making, adults aged 60 years and older may receive a single dose of a respiratory syncytial virus (RSV) vaccine, according to guidance from the Centers for Disease Control and Prevention’s Advisory Committee on...
Using shared decision making,...
10/26/2023
Pharmacy Learning Network

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use